Yadav K, Lim J, Choo J, Ow SGW, et al. Immunohistochemistry study of tumor vascular normalization and anti-angiogenic effects of sunitinib versus bevacizumab prior to dose-dense doxorubicin/cyclophosphamide chemotherapy in HER2-negative breast cancer. Breast Cancer Res Treat 2021 Dec 20. pii: 10.1007/s10549-021-06470.
PMID: 34928481